1. Home
  2. CNTB vs GROV Comparison

CNTB vs GROV Comparison

Compare CNTB & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • GROV
  • Stock Information
  • Founded
  • CNTB 2012
  • GROV 2016
  • Country
  • CNTB United States
  • GROV United States
  • Employees
  • CNTB N/A
  • GROV N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • GROV Package Goods/Cosmetics
  • Sector
  • CNTB Health Care
  • GROV Consumer Discretionary
  • Exchange
  • CNTB Nasdaq
  • GROV Nasdaq
  • Market Cap
  • CNTB 65.5M
  • GROV 59.0M
  • IPO Year
  • CNTB 2021
  • GROV N/A
  • Fundamental
  • Price
  • CNTB $1.06
  • GROV $1.43
  • Analyst Decision
  • CNTB Strong Buy
  • GROV Buy
  • Analyst Count
  • CNTB 1
  • GROV 1
  • Target Price
  • CNTB $8.00
  • GROV $2.00
  • AVG Volume (30 Days)
  • CNTB 31.2K
  • GROV 145.4K
  • Earning Date
  • CNTB 09-05-2024
  • GROV 11-12-2024
  • Dividend Yield
  • CNTB N/A
  • GROV N/A
  • EPS Growth
  • CNTB N/A
  • GROV N/A
  • EPS
  • CNTB N/A
  • GROV N/A
  • Revenue
  • CNTB $24,116,000.00
  • GROV $213,781,000.00
  • Revenue This Year
  • CNTB N/A
  • GROV N/A
  • Revenue Next Year
  • CNTB $63.90
  • GROV $0.84
  • P/E Ratio
  • CNTB N/A
  • GROV N/A
  • Revenue Growth
  • CNTB N/A
  • GROV N/A
  • 52 Week Low
  • CNTB $0.77
  • GROV $1.19
  • 52 Week High
  • CNTB $2.66
  • GROV $2.44
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 46.58
  • GROV 45.54
  • Support Level
  • CNTB $1.04
  • GROV $1.37
  • Resistance Level
  • CNTB $1.23
  • GROV $1.56
  • Average True Range (ATR)
  • CNTB 0.10
  • GROV 0.08
  • MACD
  • CNTB 0.01
  • GROV -0.01
  • Stochastic Oscillator
  • CNTB 42.37
  • GROV 7.14

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.

Share on Social Networks: